Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Hisse Senetlerindeki Sıralama #28327
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Hisse Fiyatı
$1.11
Piyasa Değeri
$27.12M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
57.93%
Ülke
KR
Ticaret Dong Sung Bio Pharm.Co.,Ltd. (002210)

Kategori

Dong Sung Bio Pharm.Co.,Ltd. (002210) için kazanç
Mar 2026 itibarıyla kazanç TTM: $-18.85M
Dong Sung Bio Pharm.Co.,Ltd. şirketinin en son finansal raporlarına göre, mevcut kazancı $-18.85M'dir. 2023 yılında şirket $-668.88K kazanç elde etti, bu 2022 yılındaki $-1.47M kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Dong Sung Bio Pharm.Co.,Ltd. için kazanç geçmişi 2007 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $-18.85M 261.93%
2024 $-5.21M 678.53%
2023 $-668.88K -54.39%
2022 $-1.47M -60.19%
2021 $-3.68M -62.99%
2020 $-9.95M 31.12%
2019 $-7.59M 26.29%
2018 $-6.01M 1,031.31%
2017 $-531.32K -74.81%
2016 $-2.11M -433.12%
2015 $633.14K -123.13%
2014 $-2.74M -7.49%
2013 $-2.96M -187.69%
2012 $3.37M 123.65%
2011 $1.51M -133.49%
2010 $-4.50M -873.29%
2009 $582.51K -85.64%
2008 $4.06M 9.40%
2007 $3.71M 0.00%
Benzer şirketler veya rakipler için kazanç